This additional information received on 06/28/2017 as follows: plaintiff allegedly received an implant on (b)(6) 2008 via the right internal jugular vein due to pulmonary embolism.Plaintiff is alleging pulmonary embolism, bleeding, thrombosis, severe pain and respiratory distress due to the device.
|
It has not been possible to further investigate or evaluate this alleged event based on the limited information provided to date via the operative note stating 'tulip, pe, bleeding, thrombosis, severe pain, respiratory distress'.Cook will reopen its investigation if further information is received.Pe is a known risk in relation to filter implant reported in the published scientific literature.Also, it is reported that the pulmonary embolism in some cases may originate from upper extremities instead of lower extremity veins.With all filters, there is some risk of further pulmonary embolism.Unknown if the reported bleeding, thrombosis, severe pain, respiratory distress is directly related to the filter and unable to identify a corresponding failure mode at this time.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.
|